The IFN-γ response cycle: decoupling tumor killing from evolutionary selection in cancer immunotherapy
4 affiliations
- 1Department of Anesthesiology, Jilin Cancer Hospital , ,
- 2Department of Ultrasound, Jilin Cancer Hospital , ,
- 3First Surgery Department of Colorectal, Gastric, and Abdominal Tumors, Jilin Cancer Hospital , ,
- 4Department of Anesthesiology, Women’s Hospital, School of Medicine, Zhejiang University, Jilin Hospital , ,
Abstract
Interferon-γ (IFN-γ) confronts the field with an apparent contradiction that is better understood as a causal consequence: the cytokine most central to antitumor immunity is also a principal driver of immune escape, and recombinant IFN-γ has both helped and harmed patients. We argue that this duality is not paradoxical but expected, escape is, in large part, the predictable evolutionary outcome of effective IFN-γ–mediated pressure. The prevailing “two faces” framing, which separates antitumor and protumor effects by dose and duration, names this discrepancy without explaining what couples its halves. Here, we reframe IFN-γ as a time-ordered IFN-γ Response Cycle: a recurring causal motif, productive execution, a self-limiting turn, and selectable resistance, running around one tunable IFNGR–JAK–STAT1–IRF1 backbone. We use “cycle” deliberately and in a restricted sense: not to imply that an individual tumor clone oscillates between sensitive and resistant states, but that this execute–feedback–select motif recurs across a tumor’s heterogeneous clonal population and across successive rounds of immune pressure and therapy. Its reversible arc, adaptive feedback and non-genetic gating, can be therapeutically reopened, whereas genetic loss of the pathway constitutes a one-way exit from the cycle rather than a return within it. Its behavior is set less by signal magnitude than by decoding, which cells read the cytokine, at what intensity, in what spatial arrangement, and over what kinetics. Synthesizing evidence across tumor killing, antigen presentation, the cellular decoding network, adaptive and chronic feedback, genetic escape and induced phenotypic adaptation, therapeutic re-engineering, and biomarkers, we argue that resistance is largely manufactured by the very signaling that mediates control: by eliminating sensitive clones, IFN-γ selects for resistant clones. This recasts IFN-γ as a self-defeating selective force and reframes the therapeutic goal as decoupling killing from selection, preserving execution while severing the feedback and selection arc. IFN-γ biomarkers currently report the presence and dominance of an inflammatory, IFN-γ-driven state rather than a defined position within the cycle; longitudinal, spatial, and compartment-resolved measurements may eventually permit a finer classification.
Related
- Rationally tailored antibiotic selection circumvents toxin-mediated evasion of killing in Mycobacterium abscessus
- Impact of different TP53 mutation subtypes on response and outcome in advanced lung adenocarcinoma receiving first-line immunotherapy or chemo-immunotherapy
- Editorial: Beyond conventional biomarkers: unlocking immunotherapy response through novel biomarkers or combinatorial approaches
- Editorial: Evolving non-invasive biomarkers: chemokines and multi-omic profiling in NSCLC immunotherapy response
- Multi-cohort validation of BRAF-PTPRT co-mutation as a predictor of favorable immunotherapy response in melanoma
BibTeX
@article{wang2026ifnγ,
title = {{The IFN-γ response cycle: decoupling tumor killing from evolutionary selection in cancer immunotherapy}},
author = {Baiyu Wang and Delong Zhao and Yuehan Ma and Chengyu Sui},
journal = {Frontiers in immunology},
year = {2026},
month = oct,
doi = {10.3389/fimmu.2026.1954319},
url = {https://europepmc.org/article/PMC/PMC13669672},
note = {CC BY},
}
RIS
TY - JOUR
TI - The IFN-γ response cycle: decoupling tumor killing from evolutionary selection in cancer immunotherapy
AU - Baiyu Wang
AU - Delong Zhao
AU - Yuehan Ma
AU - Chengyu Sui
PY - 2026
DA - 2026/10/01
JO - Frontiers in immunology
DO - 10.3389/fimmu.2026.1954319
UR - https://europepmc.org/article/PMC/PMC13669672
AB - Interferon-γ (IFN-γ) confronts the field with an apparent contradiction that is better understood as a causal consequence: the cytokine most central to antitumor immunity is also a principal driver of immune escape, and recombinant IFN-γ has both helped and harmed patients. We argue that this duality is not paradoxical but expected, escape is, in large part, the predictable evolutionary outcome of effective IFN-γ–mediated pressure. The prevailing “two faces” framing, which separates antitumor and protumor effects by dose and duration, names this discrepancy without explaining what couples its halves. Here, we reframe IFN-γ as a time-ordered IFN-γ Response Cycle: a recurring causal motif, productive execution, a self-limiting turn, and selectable resistance, running around one tunable IFNGR–JAK–STAT1–IRF1 backbone. We use “cycle” deliberately and in a restricted sense: not to imply that an individual tumor clone oscillates between sensitive and resistant states, but that this execute–feedback–select motif recurs across a tumor’s heterogeneous clonal population and across successive rounds of immune pressure and therapy. Its reversible arc, adaptive feedback and non-genetic gating, can be therapeutically reopened, whereas genetic loss of the pathway constitutes a one-way exit from the cycle rather than a return within it. Its behavior is set less by signal magnitude than by decoding, which cells read the cytokine, at what intensity, in what spatial arrangement, and over what kinetics. Synthesizing evidence across tumor killing, antigen presentation, the cellular decoding network, adaptive and chronic feedback, genetic escape and induced phenotypic adaptation, therapeutic re-engineering, and biomarkers, we argue that resistance is largely manufactured by the very signaling that mediates control: by eliminating sensitive clones, IFN-γ selects for resistant clones. This recasts IFN-γ as a self-defeating selective force and reframes the therapeutic goal as decoupling killing from selection, preserving execution while severing the feedback and selection arc. IFN-γ biomarkers currently report the presence and dominance of an inflammatory, IFN-γ-driven state rather than a defined position within the cycle; longitudinal, spatial, and compartment-resolved measurements may eventually permit a finer classification.
SN - 1664-3224
ER -